An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer (Q84077312)
Jump to navigation
Jump to search
scientific article published on 09 May 2011
Language | Label | Description | Also known as |
---|---|---|---|
English | An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer |
scientific article published on 09 May 2011 |
Statements
An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer (English)
M Moehler
A Mueller
J T Hartmann
M P Ebert
S E Al-Batran
P Reimer
M Weihrauch
F Lordick
S Biesterfeld
M Kabisch
D Wachtlin
P R Galle
German Arbeitsgemeinschaft Internistische Onkologie (AIO)